A2A Pharma's Convertible Note Round

A2A Pharma raised a round of funding on November 02, 2016.

A2A Pharmaceuticals designs computationally pre-optimized small molecule therapeutics for the treatment of cancer and antibiotic resistant bacterial infections.…

Articles about A2A Pharma's Convertible Note Round: